Novo Integrated Sciences (NVOS) Stock Statistics & Valuation Metrics

Novo Integrated Sciences has a market cap or net worth of $65.11K. The enterprise value is $3.93M.

Novo Integrated Sciences has 19,730,247 shares outstanding. The number of shares has decreased by -2.65% in one year.

Novo Integrated Sciences’s return on equity (ROE) is -1.08 and return on invested capital (ROIC) is -48.63%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Novo Integrated Sciences had revenue of 13.29M and earned -16.13M in profits. Earnings per share was -0.89.

In the last 12 months, operating cash flow was -4.75M and capital expenditures -30.35K, giving a free cash flow of -4.79M billion.

Novo Integrated Sciences pays an annual dividend of ―, resulting in a dividend yield of ―

Novo Integrated Sciences upcoming earnings date is Dec 10, 2025, After Close (Confirmed).

Novo Integrated Sciences as a current ratio of 0.37, with Debt / Equity ratio of 31.63%

In the past 12 months, Novo Integrated Sciences has paid 0.00 in taxes.

Novo Integrated Sciences EV to EBITDA ratio is -0.95, with an EV/FCF ratio of -4.16.

Novo Integrated Sciences has $1.54M in cash and marketable securities with $4.50M in debt, giving a net cash position of $2.96M billion.

Gross margin is 40.78%, with operating margin of -75.79%, and net profit margin of -121.32%.

The average price target for Novo Integrated Sciences is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell